NCT06590857
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06590857
Title Trial of 225Ac-DOTATATE (RYZ101) Alone and with Pembrolizumab in Subjects with ER+, HER2-negative Unresectable or Metastatic Breast Cancer Expressing SSTRs (TRACY-1)
Acronym TRACY-1
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors RayzeBio, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | CAN

Facility Status City State Zip Country Details
Research Facility Phoenix Arizona 85054 United States Details
Research Facility Irvine California 92618 United States Details
Research Facility San Diego California 92093 United States Details
Research Facility Santa Monica California 90404 United States Details
Research Facility Longmont Colorado 80504 United States Details
Research Facility Jacksonville Florida 32224 United States Details
Research Facility Atlanta Georgia 30322 United States Details
Research Facility Indianapolis Indiana 46202 United States Details
Research Facility Boston Massachusetts 02215 United States Details
Research Facility Detroit Michigan 48202 United States Details
Research Facility Rochester Minnesota 55905 United States Details
Research Facility St Louis Missouri 63130 United States Details
Research Facility Omaha Nebraska 68124 United States Details
Research Facility Albuquerque New Mexico 87109 United States Details
Research Facility Buffalo New York 14203 United States Details
Research Facility New York New York 10016 United States Details
Research Facility New York New York 10021 United States Details
Research Facility Cleveland Ohio 44195 United States Details
Research Facility Philadelphia Pennsylvania 19104 United States Details
Research Facility Pittsburgh Pennsylvania 15213 United States Details
Research Facility Dallas Texas 75246 United States Details
Research Facility Houston Texas 77024 United States Details
Research Facility Salt Lake City Utah 84132 United States Details
Research Facility Norfolk Virginia 23502 United States Details
Research Facility Seattle Washington 98109 United States Details
Research Facility Victoria British Columbia V8R 6V5 Canada Details
Research Facility Toronto Ontario M4N 3M5 Canada Details
Research Facility Toronto Ontario M5G 2M9 Canada Details
Research Facility Québec Quebec G1S 4L8 Canada Details
Research Facility Seoul Seoul 03080 South Korea Details
Research Facility Seoul Seoul 05505 South Korea Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field